Evidence map›Paper›PMID 24832007›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2014

Characterizing human stem cell-derived sensory neurons at the single-cell level reveals their ion channel expression and utility in pain research.

Gareth T Young, Alex Gutteridge, Heather DE Fox, Anna L Wilbrey, Lishuang Cao, Lily T Cho, Adam R Brown, Caroline L Benn, Laura R Kammonen, Julia H Friedman and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 146 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Human Dorsal Root Ganglia Neuronal Cell Line to Study Nociceptive Signaling: A New Pipeline for Pain Therapy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  7. Shaping the Action Potential in Dorsal Root and Trigeminal Ganglia Neurons: Relevance to Pain Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Decoding Pain: Next-Generation In Vitro Systems for Mechanistic Insights and Drug Discovery.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The pain target NaPflugers Archiv : European journal of physiology · 2024
    Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Gareth T YoungPfizer Neusentis, Cambridge, UK. Electronic address: Gareth.Young@pfizer.com.
Alex GutteridgePfizer Neusentis, Cambridge, UK.
Heather DE FoxPfizer Neusentis, Cambridge, UK; Current address: Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
Anna L WilbreyPfizer Neusentis, Cambridge, UK.
Lishuang CaoPfizer Neusentis, Cambridge, UK.
Lily T ChoPfizer Neusentis, Cambridge, UK.
Adam R BrownPfizer Neusentis, Cambridge, UK.
Caroline L BennPfizer Neusentis, Cambridge, UK.
Laura R KammonenPfizer Neusentis, Cambridge, UK.
Julia H FriedmanOncology Research Unit, Pfizer Global Research and Development, Pearl River, NY, USA.
Magda BictashPfizer Neusentis, Cambridge, UK.
Paul WhitingPfizer Neusentis, Cambridge, UK.
James G BilslandPfizer Neusentis, Cambridge, UK.
Edward B StevensPfizer Neusentis, Cambridge, UK.
Pfizer (United Kingdom) · GBPfizer (United States) · USUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The generation of human sensory neurons by directed differentiation of pluripotent stem cells opens new opportunities for investigating the biology of pain. The inability to generate this cell type has meant that up until now their study has been reliant on the use of rodent models. Here, we use a combination of population and single-cell techniques to perform a detailed molecular, electrophysiological, and pharmacological phenotyping of sensory neurons derived from human embryonic stem cells. We describe the evolution of cell populations over 6 weeks of directed differentiation; a process that results in the generation of a largely homogeneous population of neurons that are both molecularly and functionally comparable to human sensory neurons derived from mature dorsal root ganglia. This work opens the prospect of using pluripotent stem-cell-derived sensory neurons to study human neuronal physiology and as in vitro models for drug discovery in pain and sensory disorders.

Indexed as

Single-Cell AnalysisAniline CompoundsCell DifferentiationCells, CulturedColforsinFuransGanglia, SpinalGene Expression RegulationHumansIon ChannelsPainPluripotent Stem CellsSensory Receptor CellsA 803467Aniline CompoundsColforsinFuransIon Channels

Identifiers

PMID24832007
PMCPMC4435594
OpenAlexW2047849198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.